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Abstract
Bordetella pertussis and Bordetella parapertussis are closely related bacterial agents of whooping cough. Whole-cell pertussis (wP) vaccine
was introduced in France in 1959. Acellular pertussis (aP) vaccine was introduced in 1998 as an adolescent booster and was rapidly gen-
eralized to the whole population, changing herd immunity by speciﬁcally targeting the virulence of the bacteria. We performed a tempo-
ral analysis of all French B. pertussis and B. parapertussis isolates collected since 2000 under aP vaccine pressure, using pulsed-ﬁeld gel
electrophoresis (PFGE), genotyping and detection of expression of virulence factors. Particular isolates were selected according to their
different phenotype and PFGE type and their characteristics were analysed using the murine model of respiratory infection and in vitro
cell cytotoxic assay. Since the introduction of the aP vaccines there has been a steady increase in the number of B. pertussis and B. par-
apertussis isolates collected that are lacking expression of pertactin. These isolates seem to be as virulent as those expressing all viru-
lence factors according to animal and cellular models of infection. Whereas wP vaccine-induced immunity led to a monomorphic
population of B. pertussis, aP vaccine-induced immunity enabled the number of circulating B. pertussis and B. parapertussis isolates not
expressing virulence factors to increase, sustaining our previous hypothesis.
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Abstract
Antibiotic-resistant bacteria have emerged due to the selective pressure of antimicrobial use in humans and animals. Water plays an
important role in dissemination of these organisms among humans, animals and the environment. We studied the antibiotic resistance
patterns among 493 Escherichia coli isolates from different aquatic environmental sources collected from October 2008 to May 2009 in
Leo´n, Nicaragua. High levels of antibiotic resistance were found in E. coli isolates in hospital sewage water and in eight of 87 well-water
samples. Among the resistant isolates from the hospital sewage, ampicillin, chloramphenicol, ciproﬂoxacin, nalidixic acid, trimethoprim-
sulphamethoxazole was the most common multi-resistance proﬁle. Among the resistant isolates from the wells, 19% were resistant to
ampicillin, ceftazidime, ceftriaxone, cefotaxime, chloramphenicol, ciproﬂoxacin, gentamicin, nalidixic acid and trimethoprim-sulphameth-
oxazole. E. coli producing ESBL and harbouring blaCTX-M genes were detected in one of the hospital sewage samples and in 26% of the
resistant isolates from the well-water samples. The blaCTX-M-9 group was more prevalent in E. coli isolates from the hospital sewage
samples and the blaCTX-M-1 group was more prevalent in the well-water samples.
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Abstract
Coagulase-negative staphylococci (CoNS) are frequent contaminants of blood cultures. We aimed to evaluate the systemic inﬂammatory
response syndrome (SIRS) criteria in patients with CoNS bacteraemia for discrimination between true bloodstream infection (BSI) and
contamination. Prospective evaluation was carried out of clinical and laboratory parameters in adults with at least one positive blood
culture with CoNS at the University Hospital of Basel between 2003 and 2007. Of 3060 positive blood cultures, 654 episodes of CoNS
bacteraemia were identiﬁed. Of these, 232 (35%) were considered to be true BSI and 422 (65%) were considered to be contamination.
Overall, 80% of study participants had at least one SIRS criterion, fever being the most common, and 49% had at least two SIRS criteria.
In the multivariate analysis, independent predictors of BSI were fever or hypothermia (OR 2.93, 95% CI 1.91–4.5), tachycardia (OR
2.29, 95% CI 1.50–3.50), tachypnoea (OR 2.4, 95% CI 1.30–4.43), leucocytosis or leucopenia (OR 4.15, 95% CI 2.17–6.36) and the pres-
ence of a central venous line (OR 5.38, 95% CI 3.25–8.88). The probability of BSI increased with each additional SIRS criterion, ranging
from 42.4% in patients with only one SIRS criterion to 56.7% for those with two criteria, and 72.3% for patients with three SIRS crite-
ria. A positive blood culture with CoNS most likely represents true BSI if the patient has at least three SIRS criteria or two SIRS crite-
ria and a central venous catheter. These simple bedside criteria may guide decision to treat, decreasing the use of glycopeptides.
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